Epirium

Epirium is a clinical-stage biopharmaceutical company that has developed unique insights related to the biology of mitochondrial biogenesis and tissue function, potentially resulting in novel therapeutic approaches to currently intractable neuromuscular diseases. The company has identified and established an IP-protected platform of small molecules that constitute a new class of therapeutics with the potential to stimulate mitochondrial biogenesis and tissue regeneration. Epirium is currently planning clinical trials with its initial drug candidate in Becker muscular dystrophy. To learn more, please visit http://www.epirium.com/. Headed by a seasoned team of industry veterans with decades of experience building and leading clinical and commercial stage companies, Epirium is committed to advancing and bringing to market life-saving therapies through novel and uncharted pharmacological approaches. We are looking for passionate and collaborative individuals to join our team in an exciting biopharmaceutical environment. If you are looking for a meaningful position that could transform the lives of patients, this is the opportunity you have been waiting for.